Related Experiment Videos
Nested PCR assay for detection of granulocytic ehrlichiae
R F Massung1, K Slater, J H Owens
1National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. rfm2@cdc.gov
Journal of Clinical Microbiology
|May 23, 1998
Summary
A new nested PCR assay accurately detects granulocytic ehrlichiae in human blood and serum. This molecular diagnostic tool identified more positive cases of human granulocytic ehrlichiosis than serology.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Human granulocytic ehrlichiosis is a tick-borne illness.
- Accurate diagnostic methods are crucial for timely treatment.
Purpose of the Study:
- To develop and validate a sensitive and specific nested PCR assay for detecting granulocytic ehrlichiae.
- To compare the PCR assay's performance with serologic methods in diagnosing human granulocytic ehrlichiosis.
Main Methods:
- Nested PCR assay targeting the 16S rRNA gene.
- Analysis of acute-phase EDTA-blood and serum samples from human cases.
- DNA extraction from whole blood and serum.
- Sequencing of PCR products for confirmation.
- Application of the assay to tick and deer blood samples.
Main Results:
- The nested PCR assay detected granulocytic ehrlichiae in 5 out of 7 suspected human cases using whole blood, compared to 1 out of 7 by serology.
- The assay detected the pathogen in 3 out of 7 cases using serum.
- The limit of detection was less than 2 copies of the 16S rRNA gene.
- The assay successfully identified granulocytic ehrlichiae in Ixodes scapularis ticks and white-tailed deer blood.
- A potential variant granulocytic ehrlichia 16S rRNA gene sequence was identified in ticks and deer blood.
Conclusions:
- The developed nested PCR assay is a sensitive and specific tool for diagnosing human granulocytic ehrlichiosis.
- The assay demonstrates superior sensitivity compared to serologic methods in early disease stages.
- The PCR assay is applicable to nonhuman reservoirs, aiding in understanding disease transmission dynamics.